Skip to main content

TriSalus Life Sciences Inc. (TLSI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Law Offices of Howard G. Smith announces an investigation on behalf of TriSalus Life Sciences Inc. (“TriSalus” or the “Company”) (NASDAQ: TLSI) investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN TRISALUS LIFE SCIENCES INC. (TLSI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.

What Happened?

On May 12, 2026, TriSalus reported first quarter results, including revenue of $8.90M, a decline of 2.92% year over year. The Company further announced a cut to full year revenue guidance to $54 million to $57, a cut of $5.5 million at the midpoint compared to prior guidance.

In the accompanying earnings call, management explained “the driver of this revision includes both the lower Q1 revenues from the commercial expansion and the delayed FDA clearance timing for TriNav Advance.” Management further stated FDA clearance for TriNav Advance “is now running approximately 5 months past the 30-day MDUFA review goal.”

On this, TriSalus’s stock price fell $1.89 per share, or 41.56%, to close at $2.67 on May 13, 2026, thereby injuring investors.

Contact Us To Participate or Learn More:
If you purchased TriSalus securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Telephone: (215) 638-4847
Email: howardsmith@howardsmithlaw.com,
Visit our website at: www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  262.08
-2.93 (-1.11%)
AAPL  302.07
-0.18 (-0.06%)
AMD  444.27
-3.31 (-0.74%)
BAC  51.13
-0.09 (-0.19%)
GOOG  382.03
-2.87 (-0.75%)
META  599.30
-5.75 (-0.95%)
MSFT  418.69
-2.37 (-0.56%)
NVDA  222.17
-1.30 (-0.58%)
ORCL  189.20
+1.04 (0.55%)
TSLA  420.20
+2.94 (0.70%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.